AKEBIA THERAPEUTICS Reports Third Quarter Earnings for Fiscal Year 2023
🌥️Earnings Overview AKEBIA THERAPEUTICS ($NASDAQ:AKBA) reported a total revenue of USD 42.0 million for the third quarter of FY2023, which [...]
Akebia Therapeutics Stock Fair Value – AKEBIA THERAPEUTICS Reports Strong Second Quarter Earnings for FY 2023
☀️Earnings Overview AKEBIA THERAPEUTICS ($NASDAQ:AKBA) reported their second quarter earnings results for the 2023 fiscal year on June 30, 2023. [...]
Akebia Therapeutics’ Appeal for Kidney Disease Candidate Denied by FDA
🌧️Trending News Akebia Therapeutics ($NASDAQ:AKBA) is a leading biopharmaceutical company focused on developing innovative therapies for kidney disease. Recently, the [...]
Akebia Therapeutics Receives UK Approval for Vadadustat to Treat CKD Anemia
Trending News ☀️ Akebia Therapeutics ($NASDAQ:AKBA), a biopharmaceutical company focused on kidney disease, has received approval from the UK for [...]
Akebia Therapeutics Reports Mixed Q4 Financials Despite Beating Earnings Estimate.
Trending News ☀️ The same trend was seen in their revenue, which was $40.13M—a shortfall of $6.55M against projections. Akebia [...]
Akebia Aborts Plans for Reverse Stock Split
Trending News 🌥️ Akebia Therapeutics ($NASDAQ:AKBA), Inc., is a biopharmaceutical company that specializes in developing treatments for kidney diseases. Recently, [...]
AKEBIA THERAPEUTICS Reports Fourth Quarter FY2022 Earnings Results on March 9, 2023.
Earnings Overview On March 9 2023, AKEBIA THERAPEUTICS ($NASDAQ:AKBA) released their earnings results for the fourth quarter of FY2022, ending [...]
AKEBIA THERAPEUTICS Announces Financial Results for Fourth Quarter of FY2022
Earnings Overview AKEBIA THERAPEUTICS ($NASDAQ:AKBA) announced their financial results for the fourth quarter of FY2022, ending on December 31, 2022, [...]
AKEBIA THERAPEUTICS Reports Impressive Financial Results for Fourth Quarter of FY2022
Earnings Overview AKEBIA THERAPEUTICS ($NASDAQ:AKBA) announced their fourth quarter FY2022 financial results on March 9 2023, with total revenue of [...]
Akebia Therapeutics: A Company Profile
Trending News 🌥️ Akebia Therapeutics ($NASDAQ:AKBA), Inc. is a commercial biopharmaceutical company that discovers, develops, and commercializes novel therapeutics for [...]
